OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non–Small Cell Lung Cancer Patients Treated with Osimertinib
Ji Young Park, Seung Hun Jang, Chang Youl Lee, et al.
Tuberculosis & respiratory diseases (2022) Vol. 85, Iss. 2, pp. 155-164
Open Access | Times Cited: 5
Ji Young Park, Seung Hun Jang, Chang Youl Lee, et al.
Tuberculosis & respiratory diseases (2022) Vol. 85, Iss. 2, pp. 155-164
Open Access | Times Cited: 5
Showing 5 citing articles:
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies
Alessandra Ferro, G.M. Marinato, C. Mulargiu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104295-104295
Open Access | Times Cited: 21
Alessandra Ferro, G.M. Marinato, C. Mulargiu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104295-104295
Open Access | Times Cited: 21
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 14
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 14
New Targeted Therapy for Non-Small Cell Lung Cancer
Eunki Chung, Seung Hyun Yong, Eun Hye Lee, et al.
Tuberculosis & respiratory diseases (2022) Vol. 86, Iss. 1, pp. 1-13
Open Access | Times Cited: 8
Eunki Chung, Seung Hyun Yong, Eun Hye Lee, et al.
Tuberculosis & respiratory diseases (2022) Vol. 86, Iss. 1, pp. 1-13
Open Access | Times Cited: 8
The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib
Kuan-Chih Chen, Yen-Hsiang Huang, Kuo-Hsuan Hsu, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 317-326
Open Access | Times Cited: 3
Kuan-Chih Chen, Yen-Hsiang Huang, Kuo-Hsuan Hsu, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 317-326
Open Access | Times Cited: 3
Prognostic Significance of Pretreatment Plasma D-dimer Levels in EGFR-Positive Advanced Non-Small Cell Lung Cancer Patients Receiving Osimertinib: A Multicentre Retrospective Study
Qianfei Liu, Liping Tan, Jianbo He, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 5481-5491
Open Access
Qianfei Liu, Liping Tan, Jianbo He, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 5481-5491
Open Access
